The impact of metabolic reprogramming on tertiary lymphoid structure formation: enhancing cancer immunotherapy
Abstract Background Cancer immunotherapy has achieved unprecedented success in the field of cancer therapy. However, its potential is constrained by a low therapeutic response rate. Main body Tertiary lymphoid structure (TLS) plays a crucial role in antitumor immunity and is associated with a good p...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2025-04-01
|
| Collection: | BMC Medicine |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12916-025-04037-7 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
